Glioblastoma is the most common and most aggressive primary brain malignancy. The multimodality treatments for this tumor including surgery, radiotherapy, and chemotherapy, are still not completely satisfied. Phenethyl isothiocyanate (PEITC), one member of the isothiocyanate family, has been shown to induce apoptosis in many human cancer cells. In this study, we investigate the pro-apoptotic effects caused by PETIC in human brain glioblastoma multiforme GBM 8401 cells.
Introduction
Glioblastoma is the most common and most aggressive primary brain malignancy. Even with maximum feasible surgical resection with radiotherapy and adjuvant temozolomide (TMZ), survival rates are at a median of 14.6 months from diagnosis in molecularly unselected patients (Stupp et al., 2005) . Radiotherapy and TMZ provide better survival outcomes than radiotherapy alone to treat glioblastoma (Yang et al., 2014) . Both extent of resection and residual volume are significantly associated with survival and recurrence (Chaichana et al., 2014) . Gross total resection is associated with survival improvement, but it is not always possible because the preservation of neurological functions is necessary. The current multimodality treatments including surgery, radiotherapy, chemotherapy for this tumor are still not completely satisfying. Phenethyl isothiocyanate (PEITC) is one of the most extensively studied isothiocyanates (Moon et al., 2011) . Its effective chemopreventive activity for various tumors and no obvious toxicity in animal models have been reported (Hecht, 1995) . PEITC can induce cell cycle arrest and apoptotic cell death (Antosiewicz et al., 2008; Chen et al., 2002; Hu et al., 2003; Jakubikova et al., 2005; Kang and Wang, 2010; Telang et al., 2009; Tseng et al., 2004) . PEITC selectively kills cancer cells, but not normal cells, by generating reactive oxygen species (ROS) to trigger signal transduction, leading to cell cycle arrest and/or apoptosis (Wu and Hua, 2007) . Studies have disclosed the cell growth inhibitory effects of PEITC in human leukemia (Xu and Thornalley, 2000) , lung cancer (von Weymarn et al., 2006) , HeLa cervical cancer (Yu et al., 1998) , HT-29 colon adenocarcinoma (Hu et al., 2003) , pancreatic cancer (Nishikawa et al., 2004) , and human prostate cancer PC-3 cells (Xu et al., 2005) . In human glioma cells, PEITC inhibits the HIF-1α expression through inhibiting the Phosphoinositide 3-kinase (PI3K) and mitogen activated protein kinase (MAPK) signaling pathway, and reduces the hypoxia-induced secretion of vascular endothelial growth factor (VEGF) (Gupta et al., 2013) ; PEITC also promoted the actions of tumor necrosis factor-related apoptosis-induced ligand (TRAIL) through the upregulation of death receptor-5 (DR5) with ROS-induced-p53 and the downregulation of cell survival proteins (Lee et al., 2014) . But the overview of mechanisms of PEITC-induced apoptosis of human brain glioblastoma cells has not been understood well.
In the present study, we investigated the effects of PEITC on human brain glioblastoma cells including the induction of cell cycle arrest and apoptosis through the ROS and dysfunction of mitochondria signaling transduction pathways in GBM8401 cells.
Materials and methods

Chemicals and reagents
PEITC, dimethyl sulfoxide (DMSO), propidium iodide (PI), Trypan blue and 2,7-Dichlorodihydrofluorescein diacetate (DCFH-DA) were obtained from Sigma Chemical Co. (St. Louis, MO, USA). RPMI-1640, fetal bovine serum (FBS), L-glutamine, penicillin-streptomycin and trypsin-EDTA were purchased from Gibco BRL/Invitrogen (Carlsbad, CA, USA). Primary antibodies (BAX, BCL-2, catalase, Mn-SOD, cytochrome c, caspase-2, -3, -4, -8 and -9, PARP, GRP78, GADD153 and β-actin) and second antibodies for Western blotting were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). They were diluted in PBS Tween-20 before use. Fluo-3/AM, DiOC6 and 4′,6-diamidino-2-phenylindole (DAPI) were obtained from Molecular Probes (Invitrogen, Eugere, OR, USA).
Cell culture
Human brain glioblastoma multiforme (GBM 8401) cell line was purchased from the Food Industry Research and Development Institute (Hsinchu, Taiwan). Cells were plated onto 75 cm 2 tissue culture flasks in RPMI 1640 medium supplemented with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin, 2 mM L-glutamine, and grown at 37°C under a humidified 5% CO2 and 95% air at one atmosphere. The medium was changed every 2 days (Wang et al., 2002) .
Cell morphological changes and viability
GBM 8401 cells (2 × 10 5 cells/well) onto a 24-well plate were treated with 0, 4, 6, 8, 10, 12, and 14 μM PEITC, or 0, 500 μM TMZ and were incubated for 0, 24 and 48 h. Cells in each well were examined and we took representative photographs at 200× magnification by Nikon TE2000-U inverted microscope for morphological change examinations. After cells from each well were trypanized and collected by centrifugation at 1500 rpm for 5 min, washed twice with PBS, 5 μg/ml PI in PBS was added to the cells to determine the percentage of viable cells. Nonviable cells were stained by PI dye exclusion (indicative of an intact membrane) and displayed brighter fluorescence than the unstained (viable cells). Cells were counted by flow cytometric analysis with FACSCalibur utilizing Cell Quest software (Becton-Dickinson, San Jose, CA, USA) (Lu et al., 2010a) .
Determination of cell cycle and apoptosis by flow cytometry
GBM 8401 cells (2 × 10 5 cells/well) were grown in a 24-well plate for 24 h then treated with 0, 4, 6 and 8 μM PEITC. Cells were isolated, washed with ice-cold PBS, and then fixed in 70% ethanol overnight, followed by the re-suspension in PBS containing 40 μg/ml PI and 0.1 mg/ml RNase and 0.1% Triton X-100 in dark room for 30 min at 25°C. Cells were washed twice before cell cycle analyses were performed by using a flow cytometer (Beckton-Dickinson) equipped with an argon ion laser at 488 nm wavelength (Lu et al., 2010b) . Fluorescence intensity of the sub-G1 cell fraction represented the apoptotic cell population. Each treatment was performed in triplicate for statistical evaluation.
Annexin V-FITC/PI double staining
Cell death induced by PEITC was analyzed by flow cytometry. Cell surface exposure of phosphatidylserine (PS) in apoptotic cells was measured by Annexin V-FITC Apoptosis Detection Kit (Biovision, USA). GBM 8401 cells (1 × 10 5 cells/well) were treated with 8 μM PEITC for 24 h and then stained with Annexin V-fluorescein isothiocyanate (FITC) and PI. Cells were washed with PBS after staining, then were re-suspended in binding buffer and immediately analyzed using a fluorescence-activated cell sorting (FACS) flow cytometer (Beckman Coulter, USA) (Ho et al., 2013) . In fluorescence channels FL1 (488 nm excitation and 530 nm emission for Annexin V-FITC binding) and FL2 (488 nm excitation and red emission for PI), fluorescence from PEITC-treated and untreated cells was detected.
Detections of reactive oxygen species (ROS), Ca
2+ and mitochondrial membrane potential (ΔΨm) using flow cytometric assay GBM 8401 cells (2 × 10 5 cells/well) onto 24-well plates were treated with 0, 8 μM PEITC or 0, 500 μM TMZ and incubated for 0, 24 and 48 h. Cells were harvested from each treatment by centrifugation, washed twice with PBS and re-suspended in 500 μL of 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA) (10 μM) for ROS measurements, in 500 μL of Flou-3/AM (2.5 μg mL) for Ca 2+ level examination and in 500 μL of DiOC6 (200 nmol L) for ΔΨm determination. All samples from control and PEITC treated groups were incubated at 37°C for 30 min in the dark room at 25°C and analyzed by flow cytometry (Ho et al., 2013; Lu et al., 2010b) .
Measurements of caspase-3, -8 and -9 activities using flow cytometric assay
GBM 8401 cells (5 × 10 5 cells/well) onto 24-well plate were treated with 0, 8 μM PEITC or 0, 500 μM TMZ and incubated for 0, 24 and 48 h. Cells were harvested, washed twice with PBS then caspase-3, -8 and -9 substrates (CaspaLux8-L1D2,-CaspaLux 9-M1D2 and PhiPhiLux-G1D2) were added, respectively. Flow cytometric assay was applied to measure the activities of caspase-3, -8 and -9 (Ho et al., 2013) .
Western blotting assay
GBM 8401 cells (1 × 10 6 cells/well) onto 12-well plate were treated with 6, 8 μM PEITC and incubated for 0, 24 and 48 h to detect the apoptosis-inducing proteins. Cells were collected and lysed in lysate buffer composed of 50 μM tris (pH 8.0), 150 μM NaCl, 5 μM ethylenediaminetetraacetic acid and 0.5% NP-40 with protease inhibitor solution (Roche, Mannheim, Germany). The protein concentration from each treatment was determined by using BioRad protein assay kit. About 30 μg of protein from each sample was separated on a 10% sodium dodecyl sulfate-polyacrylamide electrophoretic gel (SDS-PAGE) and transferred to nitrocellulose membranes (GE Healthcare, NJ, USA). The blot was soaked with blocking buffer of 5% non-fat dry milk in Tris-buffered saline containing Tween-20 (TBS-T) for 1 h at 25°C. They were incubated with the specific primary antibodies. Immunoreactive proteins were detected with horseradish peroxidase conjugated secondary antibodies and detected by chemiluminescence (GE Healthcare, NJ, USA) and autoradiography by using BioMax LightFilm (Eastman Kodak, New Heaven, CT, USA) (Ho et al., 2013) .
Statistical analysis
Results were expressed as mean ± SD in triplicate (n = 3). The differences between PEITC-treated or TMZ-treated and control groups were analyzed by using one way ANOVA or the Student's t-test. The p value of less than 0.05 was considered a significant difference, *p < 0.05; #p < 0.05.
Results
PEITC induced cell morphological changes and decreased the viability of GBM8401 cells
To realize the cytotoxic effects of PEITC, GBM 8401 cells were treated with 0, 4, 6, 8, 10, 12, and 14 μM PEITC for 24 h or treated with 500 μM TMZ for 24 h. Marked morphological changes of GBM 8401 cells based on cells became smaller, round and blunt in size and some floated on medium were induced by PEITC in a dosedependent manner (Fig. 1A) . The total percentages of viable cells were measured by flow cytometric assay, PEITC decreased the percentage of viable GBM 8401 cells in a dose-and time-dependent manner, and TMZ also decreased the percentage of viable GBM 8401 cells (Fig. 1B) . The total viable cells were significantly decreased in GBM 8401 cells exposed to at least 6 μM PEITC, and by more than 50% in cells exposed to 10 μM PEITC after 48 h-treatment. Thus the concentration of 8 μM was selected in further experiments.
PEITC induced sub-G1 phase in GBM 8401 cells
The distribution of cell cycle was examined by flow cytometry after incubation with PEITC for 48 h to further examine the effects of PEITC on the cell numbers of GBM 8401 ( Fig. 2A and B) . The accumulation of the DNA contents of the GBM 8401 cells exposed to 8 μM of PEITC was significantly increased up to 25% in the G0/G1 phase in contrast to the control (Fig. 2A) . The accumulation of sub-G1 phase of the cells exposed to 4, 6, 8 μM of PEITC was significantly increased in contrast to the control (Fig. 2B) . Then these cells were analyzed after Annexin-V/PI staining by flow cytometry to confirm the induction of sub-G1 phase of GBM 8401 cells exposed to PEITC (Fig. 2C) . Results indicated that PEITC significantly induced apoptosis in GBM 8401 cells.
PEITC promoted ROS and Ca 2+ release and attenuated the levels of mitochondria membrane potential (ΔΨm) in GBM 8401 cells
Whether the induction of apoptosis in GBM 8401 cells by PEITC through ROS and Ca 2+ productions involved the levels of ΔΨm were investigated in further experiments. ROS productions were increased after GBM 8401 cells were exposed to 8 μM of PEITC for 24, 48 h, but not after cells were exposed to 500 μM of PEITC (Fig. 3A) . The levels of ΔΨm were decreased after GBM 8401 cells were treated with PEITC and TMZ (Fig. 3B ). Fluo-3/AM exhibits an increase in fluorescence when it binds Ca 2+ in the cells after being treated with PEITC. So increases in fluorescence indicate an increase in [Ca2+]I, consistent with cells that are functionally compromised. PEITC increased in [Ca2+]I in GBM 8401 cells, but TMZ decreased it (Fig. 3C) . These PEITC effects were in a time-dependent manner. These results indicated that PEITC induced growth inhibition through the ROS production, Ca 2+ release, and with involvement of mitochondria in GBM 8401 cells.
PEITC induced caspase-8 and -9 activities in GBM 8401 cells
GBM 8401 cells were treated with or without PEITC, TMZ before cells were harvested, and the activities of caspase-8, -9 and -3 and percentage of viable cells were measured by flow cytometric assay to confirm whether caspases were involved in the apoptosis induced by PEITC or TMZ. Caspase-3 activity was not significantly affected after cells were exposed to 8 μM PEITC for 24, 48 h (Fig. 4A) . But caspase-8 and -9 activities were significantly increased after cells were exposed to 8 μM PEITC for 24, 48 h ( Fig. 4B and C) . Caspase-3, -8 and -9 activities were significantly decreased after cells were exposed to 500 μM TMZ for 24, 48 h (Fig 4A-C) . Therefore caspase-8 and -9 were involved in apoptosis induced by PEITC in GBM 8401 cells.
PEITC affected apoptosis associated protein levels in GBM 8401 cells
PEITC induced apoptosis in GBM 8401 cells disclosed by the results from flow cytometric assay. To investigate protein associated with apoptosis, the protein levels were examined by Western blotting assay after GBM8401 cells were treated with PEITC (6, 8 μM) (Fig. 5) . Anti-apoptotic proteins such as Bcl-2, Mcl-1 and Bcl-xl were decreased (Fig. 5A) ; pro-apoptotic proteins such as Bax, Bad, Bid and Bak were increased (Fig. 5B) ; the levels of caspase-3, -9, -8, -2, and -4 (Fig. 5C) , FADD, Fas, Fas-L and TRAIL (Fig. 5D) , Apaf-1, Endo G, Cyto c, AIF, PARP (Fig. 5E ) were enhanced; but XIAP was inhibited (Fig. 5E) in GBM 8401 cells. The protein expression of GADD153, GRP 78 and XBP-1 (Fig. 5F ), IRE-1α, Calpain 1 and 2 (Fig. 5G ) that is associated with ER stress was promoted in GBM 8401 treated with PEITC. PEITC increased the levels of Mn SOD and Cu/Zn SOD but inhibited catalase and GST that are associated with ROS production in GBM 8401 cells (Fig. 5H) .
Discussion
The effects of PEITC on human glioma cells have been studied (Gupta et al., 2013; Lee et al., 2014) . Our study disclosed that PEITC induced apoptosis of human brain glioblastoma cells in many aspects.
PEITC induced cytotoxic effects on GBM 8401 human glioblastoma multiforme cells in vitro: it changed the morphology and decreased the viability of GBM 8401 cells in a dose-and timedependent manner (Fig. 1A and B) . The current chemotherapy agent for glioblastomas, TMZ also decreased the percentage of viable GBM 8401 cells and showed its cytotoxic effects (Fig. 1B) . How did PEITC affect the cell cycle of GBM 8401 cells? PEITC significantly increased the accumulation of the DNA contents of the GBM 8401 cells up to 25% in the G0/G1 phase in contrast to the control (Fig. 2A) . It also significantly increased the accumulation of sub-G1 phase (apoptotic population) of the cells in contrast to the control and in a dose-dependent manner (Fig. 2B) . Therefore PEITC significantly induced apoptosis in GBM 8401 cells.
PEITC induced growth inhibition through the ROS production, Ca 2+ release, and involved with mitochondria in GBM 8401 cells
(B) Fig. 3 . PEITC affected ROS and Ca 2+ production and levels of mitochondria membrane potential (ΔΨm) in GBM 8401 cells. Cells were treated with (experimental group) or without PEITC (8 μM) (control group), TMZ (500 μM) (positive control) for different time periods before being harvested to measure the ROS production by H2DCF-DA (A), the levels of ΔΨm by DiOC6 (B), and Ca 2+ production by Flou-3/AM (C) were analyzed by flow cytometric assay as described in Materials and Methods. The values presented are the mean ± S. D. (n = 3) from three independent experiments. Significantly different from vehicle control treated cells at * ,# p < 0.05. C: control, TMZ: temozolomide. (Fig. 3) . PEITC increased the levels of Mn SOD and Cu/Zn SOD, but inhibited catalase and GST that are associated with ROS production in GBM 8401 cells (Fig. 5H) . On the contrary, TMZ did not increase ROS production, Ca 2+ release, but is with involvement of mitochondria changes in GBM 8401 cells (Fig. 3) . TMZ can induce mitochondrial damage, such as the loss of ΔΨm, and lead to a decrease of mitochondrial mass in human glioblastoma U87 MG cells, which suggests that mitochondrial damage might play the role in TMZ-induced cell death (Lin et al., 2012) .
Apoptotic pathways include the extrinsic (cytoplasmic, death receptor) and intrinsic (mitochondrial) pathways (Ghobrial et al., 2005; Jin and El-Deiry, 2005) . The central effectors of apoptosis are caspases. Cell surface death receptors, such as Fas, tumor necrosis factor receptor, or TRAIL receptors are mediated through the extrinsic pathway. The extrinsic death receptor signaling pathway involving the Fas and FasL activates FADD followed by activation of caspase-8, then either activates caspase-3 directly to cause apoptosis or results in Bad activation to affect pro-apoptotic or antiapoptotic protein expression before leading to mitochondriamediated pathway (Budihardjo et al., 1999; Wolf and Green, 1999; Zhai et al., 2014) . The caspase-dependent pathway involves the Fas receptor then promotes the activations of initiator caspases (caspase-8 and -9), executioner caspases (caspase-3) for induction of apoptosis (Ghobrial et al., 2005; Jin and El-Deiry, 2005; McIlwain et al., 2013) . In our study, PEITC promoted FADD, Fas, Fas-L and TRAIL (Fig. 5D) ; PEITC did not significantly affect caspase-3 activity (Fig. 4A ), but increased caspase-8 and -9 activities ( Fig. 4B  and C) ; PEITC enhanced the levels of caspase-3, -9, -8, -2, and -4 (Fig. 5C) . Consequently, activations of initiator caspases (caspase-8 and -9) and increased expressions of caspase-3, -9, -8, -2, and -4 might involve the PEITC-induced apoptosis of GBM 8401 cells. Nevertheless, TMZ significantly decreased caspase-3, -8 and -9 activities (Fig. 4A-C) . TMZ significantly increased the activity of caspase 3 and caspase 9, but did not change the caspase 8 activity in human glioblastoma multiforme T98G cells (European Collection of Cell Cultures) (Jakubowicz-Gil et al., 2013) . Thus, TMZ has various effects on caspases or induces apoptosis through different pathways in different glioblastoma cell lines, and personalized treatments for glioblastoma are necessary.
The intrinsic (mitochondrial) pathways result in the release of apoptosis-inducing factor (AIF) or endonuclease G (Endo G) to cause apoptosis (Saelens et al., 2004; Wajant, 2002) . Cytochrome c initiates a caspase cascade by advancing apoptosome formation to provide the expression of apoptotic protease-activating factor-1 (Apaf-1). Our data indicated that PEITC enhanced Endo G, Cyto c, Apaf-1 in GBM 8401 cells (Fig. 5E ). PEITC decreased anti-apoptotic proteins such as Bcl-2, Mcl-1 and Bcl-xl ( Fig. 5A ; increased proapoptotic proteins such as Bax, Bad, Bid and Bak (Fig. 5B) ; but inhibited XIAP (Fig. 5E ) that is associated with apoptosis progression in GBM 8401 cells. According to these observations above, we suggest that PEITC induces apoptosis also through intrinsic (mitochondrial) pathways as well as extrinsic (death receptor) ones.
Endoplasmic reticulum (ER) stress has been considered one of the factors to lead to diseases through ER stress-induced apoptosis (Cui et al., 2013; Hamamura and Yokota, 2007) . In animal knockout models, GADD153 mediates apoptosis induced by ER stress in pancreatic cells and by ischemic stress induced in brain neuronal cells (Oyadomari et al., 2002; Tajiri et al., 2004) . GADD153 induces the expression of the pro-apoptotic Bcl protein, Bak, and the translocation of Bax from the cytosol to the mitochondria Lovat et al., 2003) . ER stress markers include GADD153, GRP 78, IRE-1α, XBP-1 Kim et al., 2007; Lovat et al., 2003; Oyadomari et al., 2002; Tajiri et al., 2004) . In our study, PEITC promoted the protein expression of GADD153, GRP 78 and XBP-1 (Fig. 5F ), IRE-1α, Calpain 1 and 2 (Fig. 5G ) that are associated with ER stress in GBM 8401 cells. 
Conclusions
Our experiments have established that PEITC has potent anticancer activity through the induction of apoptosis in GBM 8401 cells, and the possible signaling pathways are summarized (Fig. 6) . PEITC induces apoptosis through the extrinsic (death receptor) pathway involving the Fas and FasL, then activating FADD followed by activation of caspase-8, then either activating caspase-3 directly or through ROS production, dysfunction of mitochondria, AIF and Endo G release from mitochondria before activating caspase-3 through intrinsic (mitochondrial) pathway in GBM 8401 cells. Taken together, these findings reveal the possible molecular mechanisms and signaling pathways of the anti-cancer properties of PEITC for human brain glioblastoma cells.
